BackSunshine Biopharma- Warrants (15/02/2027) Overview
Sunshine Biopharma Inc - Warrants (15/02/2027)

Sunshine Biopharma- Warrants (15/02/2027) Return on Equity

Sunshine Biopharma- Warrants (15/02/2027) (SBFMW) has a ROE of -28.07%, below the Healthcare sector average of 29.33%.

Get informed when a big investor buys or sells

+ Follow

ROE

-28.07%

Return on Equity

-28.07%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Sunshine Biopharma- Warrants (15/02/2027) (SBFMW) FAQ

As of the most recent data, SBFMW shows a ROE of -28.07%. That is below the Healthcare sector average of 29.33%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 29.33%. Sunshine Biopharma- Warrants (15/02/2027) is at -28.07%, which is lower that average. That is roughly 195.7% below the sector mean. Use the comparison chart on this page to see how SBFMW stacks up against individual peers as well.

Check the historical chart to see whether SBFMW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sunshine Biopharma- Warrants (15/02/2027) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Sunshine Biopharma- Warrants (15/02/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -28.07%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 29.33%, while SBFMW is at -28.07%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.